Renaissance Investment Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,530
Closed -$205K 87
2017
Q3
$205K Sell
2,530
-343
-12% -$26.2K 0.09% 78
2017
Q2
$203K Sell
2,873
-3,046
-51% -$203K 0.09% 79
2017
Q1
$402K Sell
5,919
-4,651
-44% -$327K 0.18% 65
2016
Q4
$757K Sell
10,570
-19,273
-65% -$1.43M 0.36% 51
2016
Q3
$2.36M Sell
29,843
-2,179
-7% -$177K 1.13% 38
2016
Q2
$2.67M Buy
32,022
+215
+0.7% +$19.1K 1.33% 34
2016
Q1
$2.92M Sell
31,807
-65
-0.2% -$5.86K 1.47% 32
2015
Q4
$3.23M Buy
31,872
+1,040
+3% +$108K 1.57% 31
2015
Q3
$3.03M Sell
30,832
-889
-3% -$98.7K 1.58% 32
2015
Q2
$3.71M Buy
31,721
+2,136
+7% +$233K 1.74% 29
2015
Q1
$2.9M Buy
29,585
+26,505
+861% +$2.69M 1.34% 33
2014
Q4
$290K Buy
+3,080
New +$319K 0.14% 68

Other funds holding GILD

Renaissance Investment Group's GILD Position: Q4 2017 in Review

Renaissance Investment Group sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 2,530 shares — an estimated $205K sold.

Renaissance Investment Group first reported a position in GILD in Q4 2014 and held it in 12 quarters. The position peaked at $3.71M in Q2 2015. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • Renaissance Investment Group reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
  • Renaissance Investment Group sold 2,530 Gilead Sciences shares in Q4 2017, an estimated $205K.
  • Renaissance Investment Group first reported a position in Gilead Sciences in Q4 2014 and held it in 12 quarters.
  • Renaissance Investment Group's Gilead Sciences position peaked at $3.71M in Q2 2015.
  • 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Renaissance Investment Group's 13F filing for Q4 2017, filed 3 Jan 2018.